{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:47:49Z","timestamp":1792640869060,"version":"4.5.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Juvenile dermatomyositis (JDM) is a common form of inflammatory myositis in children. Vasculopathy and endothelial dysfunction play significant roles in the pathogenesis of JDM. Cardiac involvement in JDM is often underestimated, and it may be a potential indicator of poor prognosis. Cardiac dysfunction in JDM can occur both in the acute and chronic stages of the disease. Amongst the acute complications, acute congestive heart failure (CHF), myocarditis, arrhythmia, and complete heart block are common. However, these remain unrecognized due to a lack of overt clinical manifestations. Increased rates of cardiovascular abnormalities have been noted with anti-SRP and anti-Jo 1 auto-antibody positivity. Long-term follow-up studies in JDM have shown an increased prevalence of hypertension, atherosclerosis, coronary artery disease, and metabolic syndrome in adolescence and adulthood. Monitoring of body-mass index, blood pressure, and laboratory evaluation of fasting glucose and lipid profile may help in identifying metabolic syndrome in children with JDM. Steroid-sparing agents, daily exercise, and a healthy diet may reduce such long-term cardiac morbidities. Current use of multimodality imaging such as stress-echocardiography, contrast-enhanced echocardiography, cardiac magnetic resonance imaging, and positron emission tomography has increased the diagnostic yield of subclinical heart disease during acute and chronic stages of JDM. This review elaborates on different aspects of cardiac dysfunction in JDM. It also emphasizes the importance of cardiac screening in long-term follow-up of children with JDM.<\/jats:p>","DOI":"10.3389\/fmed.2022.827539","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T04:28:12Z","timestamp":1656044892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical Rheumatologists"],"prefix":"10.3389","volume":"9","author":[{"given":"Sanjib","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabal","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandiarajan","family":"Vignesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (Baltimore)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet."},{"key":"B4","first-page":"805","article-title":"Zur dermatomyositis.","volume":"36","author":"Oppenheim","year":"1899","journal-title":"Berl Klin Wochenschrift."},{"key":"B5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/art.1780250203","article-title":"Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis.","volume":"25","author":"Crowe","year":"1982","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/art.21303","article-title":"Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.","volume":"52","author":"Fall","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/ar4212","article-title":"Cardiovascular risk in pediatric-onset rheumatological diseases.","volume":"15","author":"Barsalou","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of Type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features.","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/rheumatology\/kes232","article-title":"Aerobic fitness after JDM\u2013a long-term follow-up study.","volume":"52","author":"Mathiesen","year":"2013","journal-title":"Rheumatology (Oxford)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/rheumatology\/kev376","article-title":"In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset.","volume":"55","author":"Barth","year":"2016","journal-title":"Rheumatology (Oxford)."},{"key":"B12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.socscimed.2016.01.038","article-title":"Life course SES and cardiovascular risk: heterogeneity across race\/ethnicity and gender.","volume":"152","author":"Walsemann","year":"2016","journal-title":"Soc Sci Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10067-014-2561-y","article-title":"Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients.","volume":"33","author":"Vincze","year":"2014","journal-title":"Clin Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/clc.22026","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review.","volume":"35","author":"Zhang","year":"2012","journal-title":"Clin Cardiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0182-0","article-title":"Cardiac findings in children with juvenile dermatomyositis at disease presentation.","volume":"15","author":"Cantez","year":"2017","journal-title":"Pediatr Rheumatol Online J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3346\/jkms.2009.24.4.715","article-title":"Clinical characteristics and outcomes of juvenile and adult dermatomyositis.","volume":"24","author":"Na","year":"2009","journal-title":"J Korean Med Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/s0022-3476(80)80807-9","article-title":"Juvenile dermatomyositis: a clinical and immunologic study.","volume":"96","author":"Pachman","year":"1980","journal-title":"J Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/acr.22212","article-title":"Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.","volume":"66","author":"Huber","year":"2014","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/ard.2010.137968","article-title":"Cardiac dysfunction in juvenile dermatomyositis: a case-control study.","volume":"70","author":"Schwartz","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00296-005-0030-2","article-title":"Twelve years\u2019 experience of juvenile dermatomyositis in North India.","volume":"26","author":"Singh","year":"2006","journal-title":"Rheumatol Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00296-006-0191-7","article-title":"Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.","volume":"27","author":"Karaca","year":"2006","journal-title":"Rheumatol Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/0002-9149(82)90408-8","article-title":"The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients.","volume":"50","author":"Haupt","year":"1982","journal-title":"Am J Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00005792-196607000-00001","article-title":"Dermatomyositis (systemic angiopathy) of childhood.","volume":"45","author":"Banker","year":"1966","journal-title":"Medicine (Baltimore)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine (Baltimore)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/clc.4960150415","article-title":"Pericardial tamponade in juvenile dermatomyositis.","volume":"15","author":"Pereira","year":"1992","journal-title":"Clin Cardiol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2169\/naika.72.423","article-title":"Case of dermatomyositis complicated by Adie\u2019s syndrome, segmental anhidrosis and orthostatic hypotension.","volume":"72","author":"Inukai","year":"1983","journal-title":"Nihon Naika Gakkai Zasshi."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European society of cardiology working group on myocardial and pericardial disease.","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)."},{"key":"B30","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis.","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun."},{"key":"B32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement.","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/jdv.12300","article-title":"Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy.","volume":"28","author":"Pau-Charles","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/pl00007850","article-title":"Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.","volume":"249","author":"Hengstman","year":"2002","journal-title":"J Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s10067-020-05418-4","article-title":"Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain.","volume":"40","author":"Diniz","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00296-018-4050-0","article-title":"Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies.","volume":"38","author":"Mugii","year":"2018","journal-title":"Rheumatol Int."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies.","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"key":"B38","first-page":"610","article-title":"Lipodystrophy in patients with juvenile dermatomyositis\u2013evaluation of clinical and metabolic abnormalities.","volume":"28","author":"Huemer","year":"2001","journal-title":"J Rheumatol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/met.2012.0081","article-title":"Heart rate turbulence in patients with metabolic syndrome.","volume":"11","author":"Y\u0131lmaz","year":"2013","journal-title":"Metab Syndr Relat Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/art.22108","article-title":"Study of subcutaneous fat in children with juvenile dermatomyositis.","volume":"55","author":"Verma","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/rheumatology\/kex465","article-title":"Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National inpatient sample.","volume":"57","author":"Silverberg","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"B42","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jpeds.2009.06.009","article-title":"Metabolic abnormalities and cardiovascular risk factors in children with myositis.","volume":"155","author":"Coyle","year":"2009","journal-title":"J Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jpeds.2011.05.015","article-title":"Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.","volume":"159","author":"Eimer","year":"2011","journal-title":"J Pediatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/rheumatology\/kez076","article-title":"Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan.","volume":"58","author":"Weng","year":"2019","journal-title":"Rheumatology (Oxford)."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/rheumatology\/38.11.1153","article-title":"Beware of the heart: the multiple picture of cardiac involvement in myositis.","volume":"38","author":"Riemekasten","year":"1999","journal-title":"Rheumatology (Oxford)."},{"key":"B46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00392-006-0384-9","article-title":"Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud\u2019s phenomenon.","volume":"95","author":"Tsch\u00f6pe","year":"2006","journal-title":"Clin Res Cardiol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0304-y","article-title":"Coronary artery dilation associated with anti-synthetase syndrome in an adolescent.","volume":"17","author":"Asi","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995-1998: results from the national institute of arthritis and musculoskeletal and skin diseases registry.","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-015-0053-5","article-title":"Reduced physical activity in children and adolescents with juvenile idiopathic arthritis despite satisfactory control of inflammation.","volume":"13","author":"Bohr","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases.","volume":"83","author":"Dank\u00f3","year":"2004","journal-title":"Medicine (Baltimore)."},{"key":"B51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study.","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature.","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/rheumatology\/key366","article-title":"Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.","volume":"58","author":"Moghadam-Kia","year":"2019","journal-title":"Rheumatology (Oxford)."},{"key":"B55","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib.","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/09546634.2020.1773385","article-title":"Off-label studies on ruxolitinib in dermatology: a review.","volume":"33","author":"Wu","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","article-title":"Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis.","volume":"57","author":"Kurasawa","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awy255","article-title":"A child with severe juvenile dermatomyositis treated with ruxolitinib.","volume":"141","author":"Aeschlimann","year":"2018","journal-title":"Brain."},{"key":"B59","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz005","article-title":"Janus kinase 1\/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.","volume":"142","author":"Papadopoulou","year":"2019","journal-title":"Brain."},{"key":"B60","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2018-214846","article-title":"Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials.","volume":"78","author":"Xie","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3892\/etm.2018.6992","article-title":"Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases.","volume":"17","author":"B\u01cel\u01cenescu","year":"2019","journal-title":"Exp Ther Med."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/2324709613480346","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management.","volume":"1","author":"Dhesi","year":"2013","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cardiores.2005.09.018","article-title":"Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?","volume":"69","author":"van Leuven","year":"2006","journal-title":"Cardiovasc Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5582\/irdr.2015.01033","article-title":"Azathioprine-induced atrial fibrillation.","volume":"4","author":"Dogan","year":"2015","journal-title":"Intractable Rare Dis Res."},{"key":"B65","article-title":"Effect of cyclosporine on blood pressure.","volume":"1","author":"Robert","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.12998\/wjcc.v9.i33.10382","article-title":"Heart failure as an adverse effect of infliximab for Crohn\u2019s disease: a case report and review of the literature.","volume":"9","author":"Grillo","year":"2021","journal-title":"World J Clin Cases."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B68","first-page":"1644","article-title":"Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.","volume":"31","author":"Smith","year":"2004","journal-title":"J Rheumatol."},{"key":"B69","article-title":"Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositis.","volume":"29","author":"Shenavandeh","year":"2015","journal-title":"Med J Islam Repub Iran."},{"key":"B70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0009-8981(01)00392-8","article-title":"Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis.","volume":"306","author":"Erlacher","year":"2001","journal-title":"Clin Chim Acta."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3899\/jrheum.090562","article-title":"Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies.","volume":"36","author":"Aggarwal","year":"2009","journal-title":"J Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2014-206812","article-title":"Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity.","volume":"74","author":"Hughes","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/jdi.12454","article-title":"Proposed cut-off values of the waist circumference for metabolic syndrome based on visceral fat volume in a Japanese population.","volume":"7","author":"Tsukiyama","year":"2016","journal-title":"J Diabetes Investig."},{"key":"B74","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11604-016-0540-8","article-title":"Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging.","volume":"34","author":"Radmard","year":"2016","journal-title":"Jpn J Radiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1385\/jcd:6:2:75","article-title":"Clinical applications of body composition measurements using DXA.","volume":"6","author":"Albanese","year":"2003","journal-title":"J Clin Densitom."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3899\/jrheum.130044","article-title":"Left ventricular diastolic dysfunction \u2014- early cardiac impairment in patients with polymyositis\/dermatomyositis: a tissue Doppler imaging study.","volume":"40","author":"Lu","year":"2013","journal-title":"J Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00415-014-7623-1","article-title":"Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography.","volume":"262","author":"Rosenbohm","year":"2015","journal-title":"J Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF01731845","article-title":"Cardiac and skeletal muscle scintigraphy in dermato\u2013 and polymyositis: clinical implications.","volume":"23","author":"Buchpiguel","year":"1996","journal-title":"Eur J Nucl Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/CIRCIMAGING.113.000345","article-title":"Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography.","volume":"6","author":"Yonetsu","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-2","article-title":"Can cardiac computed tomography predict cardiovascular events in asymptomatic type-2 diabetics?: results of a long term follow-up.","volume":"14","author":"Faustino","year":"2014","journal-title":"BMC Cardiovasc Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40846-015-0086-8","article-title":"Novel methods for pulse wave velocity measurement.","volume":"35","author":"Pereira","year":"2015","journal-title":"J Med Biol Eng."},{"key":"B82","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijcard.2017.11.032","article-title":"Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: an appraisal of the diagnostic strengths and limitations of the Lake Louise criteria.","volume":"252","author":"Mavrogeni","year":"2018","journal-title":"Int J Cardiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.21037\/apm-19-650","article-title":"The quest for diagnostic approaches of cardiac involvement in polymyositis and dermatomyositis.","volume":"9","author":"Liu","year":"2020","journal-title":"Ann Palliat Med."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open."},{"key":"B85","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab.","volume":"75","author":"Touma","year":"2008","journal-title":"Joint Bone Spine."},{"key":"B86","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.autrev.2016.01.015","article-title":"Cardiac involvement in polymyositis and dermatomyositis.","volume":"15","author":"Danieli","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis.","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3899\/jrheum.090953","article-title":"Treatment approaches to juvenile dermatomyositis (JDM) across North America: the childhood arthritis and rheumatology research alliance (CARRA) JDM treatment survey.","volume":"37","author":"Stringer","year":"2010","journal-title":"J Rheumatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00059-018-4719-x","article-title":"Treatment options in myocarditis and inflammatory cardiomyopathy : focus on i.?v. immunoglobulins.","volume":"43","author":"Maisch","year":"2018","journal-title":"Herz."},{"key":"B90","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/CIRCULATIONAHA.113.001372","article-title":"Diagnosis and treatment of myocarditis in children in the current era.","volume":"129","author":"Canter","year":"2014","journal-title":"Circulation."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.repc.2017.11.013","article-title":"Diet in patients with metabolic syndrome: what is the ideal macronutrient composition?","volume":"37","author":"Tim\u00f3teo","year":"2018","journal-title":"Rev Port Cardiol (Engl Ed)."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1007\/s10067-019-04738-4","article-title":"Exercise training attenuates insulin resistance and improves \u03b2-cell function in patients with systemic autoimmune myopathies: a pilot study.","volume":"38","author":"de Oliveira","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.phrs.2006.03.012","article-title":"Hypolipidemic therapy for the metabolic syndrome.","volume":"53","author":"Cignarella","year":"2006","journal-title":"Pharmacol Res."},{"key":"B94","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy.","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-012-1986-4","article-title":"Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis assessment and clinical studies group survey.","volume":"31","author":"Charles-Schoeman","year":"2012","journal-title":"Clin Rheumatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.827539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T04:28:28Z","timestamp":1656044908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.827539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":97,"alternative-id":["10.3389\/fmed.2022.827539"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.827539","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"827539"}}